DHR · News · 20260802N
Guidance / Outlook
DANAHER CORP /DE/ · 2026-08-02 · Importance 20 · Surprise 24
Danaher reaffirmed its previously communicated financial guidance for the third quarter and full year 2026. The guidance was maintained in conjunction with the October 1, 2026 CEO transition. Third-party reporting said the company continues to face bioprocessing shipment-timing delays and respiratory-related issues, although those items were not described as changing the reaffirmed outlook.